###begin article-title 0
Genetic Analysis of the Role of Proteolysis in the Activation of Latent Myostatin
###end article-title 0
###begin p 1
Conceived and designed the experiments: SL. Performed the experiments: SL. Analyzed the data: SL. Contributed reagents/materials/analysis tools: SL. Wrote the paper: SL.
###end p 1
###begin p 2
###xml 523 531 523 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1152 1156 1152 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 1529 1536 1529 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">Mice</span>
Myostatin is a secreted protein that normally acts to limit skeletal muscle growth. As a result, there is considerable interest in developing agents capable of blocking myostatin activity, as such agents could have widespread applications for the treatment of muscle degenerative and wasting conditions. Myostatin normally exists in an inactive state in which the mature C-terminal portion of the molecule is bound non-covalently to its N-terminal propeptide. We previously showed that this latent complex can be activated in vitro by cleavage of the propeptide with members of the bone morphogenetic protein-1/tolloid (BMP-1/TLD) family of metalloproteases. Here, I show that mice engineered to carry a germline point mutation rendering the propeptide protease-resistant exhibit increases in muscle mass approaching those seen in mice completely lacking myostatin. Mice homozygous for the point mutation have increased muscling even though their circulating levels of myostatin protein are dramatically increased, consistent with an inability of myostatin to be activated from its latent state. Furthermore, I show that a loss-of-function mutation in Tll2, which encodes one member of this protease family, has a small, but significant, effect on muscle mass, implying that its function is likely redundant with those of other family members. These findings provide genetic support for the hypothesis that proteolytic cleavage of the propeptide by BMP-1/TLD proteases plays a critical role in the activation of latent myostatin in vivo and suggest that targeting the activities of these proteases may be an effective therapeutic strategy for enhancing muscle growth in clinical settings of muscle loss and degeneration.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 130 133 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee1">[1]</xref>
###xml 159 162 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-McPherron1">[2]</xref>
###xml 171 174 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Grobet1">[3]</xref>
###xml 175 178 173 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Grobet2">[6]</xref>
###xml 186 189 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Clop1">[7]</xref>
###xml 196 199 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Mosher1">[8]</xref>
###xml 212 215 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Schuelke1">[9]</xref>
###xml 471 474 469 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-McPherron1">[2]</xref>
###xml 1071 1075 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Bogdanovich1">[10]</xref>
###xml 1076 1080 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee2">[14]</xref>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 164 170 <span type="species:ncbi:9913">cattle</span>
###xml 180 185 <span type="species:ncbi:9940">sheep</span>
###xml 191 195 <span type="species:ncbi:9615">dogs</span>
###xml 205 211 <span type="species:ncbi:9606">humans</span>
###xml 278 282 <span type="species:ncbi:10090">Mice</span>
###xml 845 850 <span type="species:ncbi:9606">human</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
Myostatin is a transforming growth factor-ss (TGF-ss) family member that plays a critical role in regulating skeletal muscle mass [1]. Genetic studies in mice [2], cattle [3]-[6], sheep [7], dogs [8], and humans [9] have shown that myostatin normally acts to limit muscle mass. Mice engineered to lack myostatin have about a doubling of skeletal muscle weights throughout the body, which results from a combination of increased fiber numbers and muscle fiber hypertrophy [2]. Hence, myostatin appears to play at least two distinct roles in regulating muscle mass, one to regulate the number of muscle fibers that are formed during development and a second to regulate muscle fiber growth. Based on this latter function, there has been considerable interest in developing agents capable of inhibiting myostatin activity for both agricultural and human therapeutic applications. In this respect, several engineered and endogenous myostatin binding proteins have been demonstrated to be capable of increasing muscle growth when administered to normal and/or dystrophic mice [10]-[14].
###end p 4
###begin p 5
###xml 323 327 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 329 333 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee3">[15]</xref>
###xml 334 338 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Thies1">[16]</xref>
###xml 510 514 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Zimmers1">[17]</xref>
###xml 515 519 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Hill2">[19]</xref>
###xml 593 601 592 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 665 669 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 671 675 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Zimmers1">[17]</xref>
###xml 778 782 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 940 947 939 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 175 190 <span type="species:ncbi:10029">Chinese hamster</span>
Like other TGF-ss family members, myostatin is synthesized as a precursor protein that is cleaved by furin proteases to generate the active C-terminal dimer. When produced in Chinese hamster ovary cells, the C-terminal dimer remains bound to the N-terminal propeptide, which maintains myostatin in a latent, inactive state [12], [15]-[16]. Most, if not all, of the myostatin protein that circulates in the blood also appears to exist in an inactive complex with a variety of proteins, including the propeptide [17]-[19]. We showed previously that the latent form of myostatin can be activated in vitro by dissociating the complex with either acid or heat treatment [12], [17] or by proteolytic cleavage of the propeptide with members of the BMP-1/TLD family of metalloproteases [12]. Here, I present genetic evidence suggesting that proteolytic cleavage of the propeptide may be the primary mechanism by which latent myostatin is activated in vivo.
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation and analysis of mice with a protease-resistant form of the propeptide
###end title 7
###begin p 8
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
In previous studies, we showed that the purified complex of myostatin propeptide and C-terminal dimer can be cleaved at aspartate residue 76 by members of the BMP-1/TLD family of metalloproteases and that cleavage at this site in the propeptide results in activation of the latent complex [12]. Furthermore, we showed that changing this aspartate residue to alanine (D76A) affected neither the ability of the propeptide to form a complex with myostatin nor the ability of the latent complex to be activated by heat treatment but completely blocked the ability of the complex to be cleaved and activated by members of the BMP-1/TLD family. Finally, we showed that unlike the wild type propeptide, a form of the propeptide containing the D76A amino acid change could cause significant muscle growth when administered to mice.
###end p 8
###begin p 9
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 209 218 209 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g001">Figure 1a</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lakso1">[20]</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 549 564 <span type="species:ncbi:10090">transgenic mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
To determine whether this mechanism for activating latent myostatin functions in vivo, I generated mice in which the aspartate to alanine change in the propeptide was introduced into the germline. As shown in Figure 1a, the D76A point mutation was engineered into a myostatin genomic construct, which was used for homologous targeting in embryonic stem cells. Following injection of the targeted embryonic stem cells into blastocysts, I obtained mice that transmitted the mutant allele through the germline. These mice were then crossed to EIIa-cre transgenic mice [20] to remove the neo cassette that had been placed into the first intron. In order to rule out the possibility that any observed effects might result from the LoxP site remaining following removal of the neo cassette, I also generated mice carrying this LoxP site but which were wild type at aspartate 76. Both of these lines were backcrossed at least 6 times to C57 BL/6 mice prior to analysis, and all analysis was carried out on both female and male mice at 10 weeks of age.
###end p 9
###begin title 10
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Generation of mice carrying a Mstn point mutation rendering the propeptide resistant to cleavage by BMP-1/TLD proteases.
###end title 10
###begin p 11
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 377 381 377 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A</sup>
###xml 373 381 373 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A</sup></italic>
###xml 399 403 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP</sup>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>LoxP</sup></italic>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 515 518 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 539 548 539 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 535 548 535 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 829 832 829 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 825 832 825 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 842 851 842 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 838 851 838 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 960 963 960 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-McPherron1">[2]</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee3">[15]</xref>
###xml 1101 1105 1101 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee3">[15]</xref>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1073 1088 <span type="species:ncbi:10029">Chinese hamster</span>
(a) Gene targeting strategy. Black and stippled boxes represent coding exons for the propeptide and C-terminal domain, respectively. The location of the point mutation (D76A) is denoted by an asterisk, and LoxP sites are denoted by triangles. Removal of the neo cassette using EIIa-cre mice resulted in Mstn alleles containing a single LoxP site (in intron 1) either with (MstnD76A) or without (MstnLoxP) the point mutation. (b) Northern analysis of Mstn RNA expression in mutant mice. Muscle RNA isolated from Mstn-/-, wild type, and MstnD76A/D76A mice was electrophoresed, blotted, and hybridized with a Mstn probe. The blots were re-hybridized with a probe for the S26 ribosomal protein to control for loading. (c) Analysis of myostatin protein in mutant mice. Hydroxylapatite-bound serum samples isolated from wild type, Mstn-/-, and MstnD76A/D76A mice were electrophoresed, blotted, and probed with antiserum directed against either the C-terminal domain [2] or the propeptide [15]. In each gel, the first lane contains purified myostatin latent complex isolated from Chinese hamster ovary cells [15].
###end p 11
###begin p 12
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001628-t001">Table 1</xref>
###xml 24 33 24 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g002">Figure 2a</xref>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
As shown in Table 1 and Figure 2a, mice homozygous for the LoxP allele but wild type at aspartate 76 had muscle weights that were comparable to those of wild type mice. In contrast, mice carrying the D76A point mutation exhibited significant increases in muscle mass in all four skeletal muscles that were examined as well as in both males and females. Moreover, the effect of the point mutation was dose-dependent, with mice heterozygous for the mutation exhibiting increases of 14-19% and mice homozygous for the mutation exhibiting increases of 60-99% compared to wild type mice. This overall pattern was qualitatively similar to that observed in mice heterozygous or homozygous for a Mstn null allele; however, the effect of the point mutation was slightly reduced in magnitude compared to that of the null allele.
###end p 12
###begin title 13
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Analysis of muscles of mutant mice.
###end title 13
###begin p 14
###xml 35 44 35 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 31 44 31 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 157 164 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001628-t001">Table 1</xref>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 419 428 419 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 415 428 415 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
(a) Muscle weight increases in MstnD76A/D76A mice. Numbers represent percent increases relative to wild type mice and were calculated from the data shown in Table 1. Muscles analyzed were: pectoralis (red), triceps (gray), quadriceps (blue), and gastrocnemius (green). (b) Distribution of fiber diameters. Gray bars represent muscle fibers from wild type mice, and red bars represent muscle fibers from Mstn-/- and MstnD76A/D76A.
###end p 14
###begin title 15
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Muscle weights (mg) of Mstn and Tll2 mutant mice.
###end title 15
###begin p 16
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.0001 vs. wild type;
###end p 16
###begin p 17
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.001 vs. wild type;
###end p 17
###begin p 18
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 15 24 15 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 15 24 15 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>D76A/D76A</sup></italic>
###xml 15 24 15 24 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>D76A/D76A</sup></italic></bold>
p<0.05 vs. MstnD76A/D76A;
###end p 18
###begin p 19
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 15 24 15 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 15 24 15 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>D76A/D76A</sup></italic>
###xml 15 24 15 24 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>D76A/D76A</sup></italic></bold>
p<0.01 vs. MstnD76A/D76A;
###end p 19
###begin p 20
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 vs. wild type;
###end p 20
###begin p 21
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.01 vs. wild type;
###end p 21
###begin p 22
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 17 26 17 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 17 26 17 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>D76A/D76A</sup></italic>
###xml 17 26 17 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>D76A/D76A</sup></italic></bold>
p<0.0001 vs. MstnD76A/D76A;
###end p 22
###begin p 23
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 16 25 16 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>D76A/D76A</sup></italic>
###xml 16 25 16 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>D76A/D76A</sup></italic></bold>
p<0.001 vs. MstnD76A/D76A
###end p 23
###begin p 24
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-McPherron1">[2]</xref>
###xml 344 351 344 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001628-t002">Table 2</xref>
###xml 356 365 356 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g002">Figure 2b</xref>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 410 417 410 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee4">[21]</xref>
###xml 825 828 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 821 828 821 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1030 1039 1030 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 1026 1039 1026 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 1098 1101 1098 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1094 1101 1094 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 1108 1115 1108 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001628-t002">Table 2</xref>
###xml 1120 1129 1120 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g002">Figure 2b</xref>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
In previous studies, we showed that the increases in muscle mass seen in Mstn null mice result from a combination of increased fiber numbers and muscle fiber hypertrophy [2]. To determine whether the same is true for mice carrying the D76A point mutation, I carried out morphometric analysis of the gastrocnemius/plantaris muscles. As shown in Table 2 and Figure 2b, total fiber number was increased by 48% in Mstn-/- mice compared to wild type mice, and mean fiber diameter at the widest point of the muscles was increased by 16%, which would be predicted to result in an approximately 34% increase in cross-sectional area. Hence, consistent with what I reported previously [21], increases in both fiber number and fiber size appeared to contribute to the increase in mass seen in the gastrocnemius/plantaris muscles in Mstn-/- mice. Similarly, both muscle fiber number and mean fiber diameter were increased in the gastrocnemius/plantaris muscles of mice homozygous for the D76A point mutation, although the effects seen in MstnD76A/D76A mice appeared to be slightly lower than those seen in Mstn-/- mice (Table 2 and Figure 2b).
###end p 24
###begin title 25
Morphometric analysis of gastrocnemius/plantaris muscles.
###end title 25
###begin p 26
calculated as relative fiber diameter squared,
###end p 26
###begin p 27
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+/+</sup></italic>
###xml 16 19 16 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>+/+</sup></italic></bold>
p<0.001 vs. Mstn+/+,
###end p 27
###begin p 28
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+/+</sup></italic>
###xml 15 18 15 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>+/+</sup></italic></bold>
p<0.01 vs. Mstn+/+;
###end p 28
###begin p 29
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+/+</sup></italic>
###xml 15 18 15 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sup>+/+</sup></italic></bold>
p<0.05 vs. Mstn+/+
###end p 29
###begin p 30
###xml 28 37 28 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 24 37 24 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 488 497 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g001">Figure 1b</xref>
###xml 556 560 556 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 603 612 603 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 599 612 599 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A</italic>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 1162 1166 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee3">[15]</xref>
###xml 1334 1343 1334 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 1330 1343 1330 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 1377 1386 1377 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g001">Figure 1c</xref>
###xml 1491 1500 1491 1500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 1487 1500 1487 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 1680 1689 1680 1689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 1676 1689 1676 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 1344 1348 <span type="species:ncbi:10090">mice</span>
###xml 1371 1375 <span type="species:ncbi:10090">mice</span>
###xml 1501 1505 <span type="species:ncbi:10090">mice</span>
###xml 1557 1561 <span type="species:ncbi:10090">mice</span>
###xml 1690 1694 <span type="species:ncbi:10090">mice</span>
Hence, the phenotype of MstnD76A/D76A mice closely resembled the phenotype of Mstn null mice. Although these findings were consistent with the point mutation rendering the latent myostatin complex resistant to activation by BMP-1/TLD proteases, it was important to rule out the possibility that the point mutation caused increased muscling by decreasing myostatin expression levels. I first examined effects of the D76A point mutation on Mstn RNA levels by Northern analysis. As shown in Figure 1b, analysis of four different muscles showed that levels of Mstn mRNA were not decreased in muscles of MstnD76A/D76A mice compared to wild type mice and, in fact, actually appeared to be even slightly increased. Next, I examined effects of the D76A mutation on circulating myostatin protein levels. Because I was unable to detect myostatin protein directly in serum samples by Western analysis using antibodies that we had prepared against recombinant myostatin protein, I partially purified the complex of myostatin propeptide and C-terminal dimer from serum by taking advantage of the ability of both the wild type and mutant complex to bind hydroxylapatite [12], [15]. Western analysis of the hydroxylapatite-bound material revealed that serum levels of both the propeptide and the C-terminal domain were dramatically increased in MstnD76A/D76A mice compared to wild type mice (Figure 1c); in fact, in these experiments, the C-terminal domain was readily detectable in serum samples from MstnD76A/D76A mice but only barely so in serum samples from wild type mice. Hence, even though the complex of mutant propeptide and C-terminal dimer appears to accumulate to high levels in MstnD76A/D76A mice, the latent complex is unable to be activated, thereby resulting in increased muscle growth.
###end p 30
###begin title 31
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Generation and characterization of Tll2 mutant mice
###end title 31
###begin p 32
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp1</italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll1</italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp1</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll1</italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Scott1">[23]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Ge1">[22]</xref>
###xml 829 836 829 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The BMP-1/TLD family consists of four proteins, BMP-1, TLD, TLL-1, and TLL-2, encoded by three distinct genes (Bmp1, Tll1, and Tll2; for review, see ref. 22). All four of these proteases are capable of cleaving and activating the latent myostatin complex in vitro[12]. For two reasons, TLL-2 seemed to be an attractive candidate for the protease that might be important for regulating myostatin latency. First, unlike Bmp1 and Tll1, Tll2 is expressed during limb development specifically in skeletal muscle [23]. Second, although all four proteases are capable of cleaving the myostatin propeptide, the range of substrates on which TLL-2 is active appears to be much more narrow than those of other family members [22], raising the possibility that regulation of myostatin activity might be one of the primary functions of TLL-2 in vivo.
###end p 32
###begin p 33
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 246 255 246 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g003">Figure 3a</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 648 663 <span type="species:ncbi:10090">transgenic mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">Mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
To determine whether TLL-2 plays a role in regulating myostatin latency in vivo, I generated mice carrying a targeted deletion of the Tll2 gene. The Tll2 gene consists of 21 exons, with the protease domain being encoded in exons 4-8. As shown in Figure 3a, I generated a construct in which a LoxP site and a LoxP/neo cassette were introduced into introns 6 and 7, respectively. Following homologous recombination in embryonic stem cells and transfer of the targeted cells into blastocysts, several chimeric mice were obtained that transmitted the targeted allele through the germline. Offspring from the chimeric mice were then mated with EIIa-cre transgenic mice to generate mice in which exon 7 had been completely deleted. The deletion allele was then backcrossed six times onto a C57 BL/6 genetic background prior to analysis. Mice homozygous for the deletion were viable and fertile, and all analysis was carried out on 10-week old mice.
###end p 33
###begin title 34
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation and analysis of mice carrying a loss-of-function mutation in the Tll2 gene.
###end title 34
###begin p 35
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 253 256 253 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 249 256 249 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2<sup>&#8722;/&#8722;</sup></italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 483 486 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2<sup>&#8722;/&#8722;</sup></italic>
###xml 599 606 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001628-t001">Table 1</xref>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
(a) Gene targeting strategy. Locations of exons 6-9 are shown as black boxes, and LoxP sites are denoted by triangles. (b) Northern analysis of Tll2 expression levels. Twenty micrograms of poly A-selected brain RNA isolated from either wild type or Tll2-/- mice were electrophoresed, blotted, and hybridized with a Tll2 probe corresponding to exons 1-3. The blot was re-hybridized with a probe for the S26 ribosomal protein to control for loading. (c) Muscle weight increases in Tll2-/- mice. Numbers represent percent increases relative to wild type mice and were calculated from the data shown in Table 1. Muscles analyzed were: pectoralis (red), triceps (gray), quadriceps (blue), and gastrocnemius (green).
###end p 35
###begin p 36
###xml 665 668 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 661 668 661 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2<sup>&#8722;/&#8722;</sup></italic>
###xml 687 696 687 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g003">Figure 3b</xref>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 890 893 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 886 893 886 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2<sup>&#8722;/&#8722;</sup></italic>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
A deletion of exon 7 is predicted to remove approximately half of the protease domain of TLL-2 as well as cause a frameshift leading to a premature termination codon. Hence, this mutant allele would be expected to result in a severely truncated product lacking over 85% of the normal protein, including not only half of the protease domain but also all of the CUB and EGF domains. The presence of a premature termination codon near the 5' end of the mRNA also raised the possibility that the mutant transcript might be subject to nonsense-mediated decay. To determine whether the mutant transcript was unstable, I compared RNA levels in brains of wild type and Tll2-/- mice. As shown in Figure 3b, the Tll2 transcript was readily detected by Northern analysis of poly A-selected brain RNA prepared from wild type mice. In contrast, the deletion transcript was undetectable in brains of Tll2-/- mice, consistent with nonsense-mediated decay. Hence, the deletion of exon 7 appears to result not only in a severely truncated protein consisting of about half of the protease domain but also in greatly reduced mRNA levels and therefore likely results in a severe, if not complete, reduction in TLL-2 activity.
###end p 36
###begin p 37
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 145 152 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001628-t001">Table 1</xref>
###xml 157 166 157 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001628-g003">Figure 3c</xref>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2<sup>&#8722;/&#8722;</sup></italic>
###xml 619 622 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 615 622 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2<sup>&#8722;/&#8722;</sup></italic>
###xml 676 685 676 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 672 685 672 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 779 786 779 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
To determine whether TLL-2 may play a role in regulating myostatin activity, I measured effects of the Tll2 mutation on muscle mass. As shown in Table 1 and Figure 3c, mice homozygous for the Tll2 mutation exhibited slightly increased muscle weights compared to wild type mice. The increases in muscle weights in Tll2-/- mice were more pronounced in females, which exhibited statistically significant increases ranging from 9-12% depending on the specific muscle. Based on these results, TLL-2 appears to play at least some role in regulating muscle growth; however, the fact that the muscle mass increases seen in Tll2-/- mice were significantly lower than those seen in MstnD76A/D76A mice implies that TLL-2 cannot be the sole protease involved in regulating myostatin latency in vivo.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee3">[15]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Thies1">[16]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Zimmers1">[17]</xref>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Hill1">[18]</xref>
###xml 632 639 632 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 889 897 889 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 968 975 968 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
Here, I have presented the results of genetic studies investigating the mechanisms by which myostatin activity is regulated in vivo. Previous studies have demonstrated that following processing of the myostatin precursor protein by furin proteases, the propeptide remains non-covalently bound to the mature C-terminal dimer and maintains it in a latent, inactive state [12], [15], [16]. This latent complex of the propeptide and C-terminal dimer also appears to represent the predominant form of myostatin that circulates in the blood [17], [18]. A major question regarding the mechanisms by which myostatin regulates muscle growth in vivo is how myostatin is activated from this latent state. In an earlier study, we demonstrated that members of the BMP-1/TLD family of metalloproteases are capable of cleaving the myostatin propeptide and thereby activating the latent myostatin complex in vitro[12]. In order to determine whether this activation mechanism operates in vivo, I analyzed the effect of blocking this pathway in mice.
###end p 39
###begin p 40
###xml 414 422 414 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A</italic>
###xml 767 776 767 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 763 776 763 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 1079 1088 1079 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 1075 1088 1075 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 1421 1428 1421 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1089 1093 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1496 1500 <span type="species:ncbi:10090">mice</span>
###xml 1539 1543 <span type="species:ncbi:10090">mice</span>
We showed previously that members of the BMP-1/TLD family can cleave the myostatin propeptide immediately N-terminal to aspartate residue 76. Furthermore, we showed that changing this aspartate to alanine (D76A) had no effect on the ability of the propeptide to form a latent complex with the mature myostatin C-terminal dimer but rendered the propeptide completely resistant to proteolysis by BMP-1/TLD proteases in vitro[12]. Here, I have analyzed the effect of introducing this D76A point mutation into the endogenous Mstn gene by homologous targeting in mice. I have presented data showing that mice homozygous for this D76A mutation exhibit significant increases in muscle mass and, as in the case of mice completely lacking myostatin, that the increases in MstnD76A/D76A mice result from a combination of increased fiber numbers and increased fiber sizes. Remarkably, these mice exhibit significant increases in muscle mass despite the fact that the circulating levels of myostatin protein in these mice are dramatically increased compared to wild type mice. Hence, in MstnD76A/D76A mice, myostatin appears to exist in a latent state that, for the most part, cannot be activated, and as a result, this latent complex accumulates to high levels. Based on the enhanced muscling seen in these mutant mice, it seems clear that proteolysis of the propeptide is the major mechanism by which latent myostatin is activated in vivo; however, the fact that the increases in muscle mass seen in these mice are slightly lower than those seen in mice completely lacking myostatin implies that this cannot be the sole mechanism for activating the latent complex.
###end p 40
###begin p 41
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Wolfman1">[12]</xref>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 617 624 617 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8211;/&#8211;</sup></italic>
###xml 632 641 632 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D76A/D76A</sup>
###xml 628 641 628 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>D76A/D76A</sup></italic>
###xml 749 756 749 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">Mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
The BMP-1/TLD family consists of four proteins, each of which is capable of cleaving and activating the latent myostatin complex in vitro[12]. Based on its expression pattern and substrate specificity, one of these family members, TLL-2, appeared to be an attractive candidate for the protease that might be responsible for activating latent myostatin in vivo. To investigate this possibility, I generated and analyzed mice carrying a targeted mutation in the Tll2 gene. Mice homozygous for the Tll2 mutation exhibit increases in muscle mass, but these increases are relatively small compared to those seen in either Mstn-/- or MstnD76A/D76A mice. These results suggest either that TLL-2 plays a relatively minor role in activating latent myostatin in vivo or that its function is redundant with those of other members of this protease family.
###end p 41
###begin p 42
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp1</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll2</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp1</italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll1</italic>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Scott1">[23]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Takahara2">[25]</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Suzuki1">[26]</xref>
###xml 576 580 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Clark1">[27]</xref>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
Clearly, the next step will be to examine the potential roles of the other members of the BMP-1/TLD family in regulating myostatin latency. In this regard, it will be important to investigate the roles of both BMP-1/TLD and TLL-1, as Bmp1 has been shown to be expressed in skeletal muscle during development in an overlapping pattern with Tll2, and both Bmp1 and Tll1 have been shown to be expressed in adult skeletal muscle [23]-[25]. Given that genetic studies have shown that complete loss of either BMP-1/TLD or TLL-1 causes perinatal or embryonic lethality in mice [26], [27], analysis of the roles of these proteases in regulating muscle mass will require the generation of mice in which each of these proteases can be eliminated in a tissue-specific manner.
###end p 42
###begin p 43
The elucidation of the precise roles played by each of these proteases will be essential for targeting this regulatory mechanism for the development of drugs capable of blocking myostatin activity. These studies are particularly important in that the relevant protease or proteases would represent an attractive target for small molecule drug screening. Although several biologics have been identified that can target myostatin activity and promote muscle growth, the development of small molecule inhibitors capable of mimicking these effects has been hampered by the general paucity of suitable targets for drug screening. The studies presented here should provide a strong impetus for further pursuing these proteases for the development of agents capable of promoting muscle growth in clinical settings where increasing muscle strength may be beneficial.
###end p 43
###begin title 44
Methods
###end title 44
###begin p 45
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-McPherron1">[2]</xref>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mstn<sup>&#8722;/&#8722;</sup></italic>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-McPherron1">[2]</xref>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
Targeting constructs were generated from phage clones isolated from a 129 SvJ genomic library [2]. R1 embryonic stem cells were kindly provided by A. Nagy, R. Nagy, and W. Abramow-Newerly. Blastocyst injections of targeted clones were carried out by the Johns Hopkins Transgenic Core Facility. All mice, including Mstn-/- mice [2], were backcrossed at least 6 times onto a C57 BL/6 background prior to analysis. All analysis was carried out on 10-week old mice. All animal experiments were carried out in accordance with protocols that were approved by the Institutional Animal Care and Use Committee at Johns Hopkins University School of Medicine.
###end p 45
###begin p 46
For measurement of muscle weights, individual muscles were dissected from both sides of the animal, and the average weight was calculated. For morphometric analysis, the gastrocnemius and plantaris muscles were sectioned to their widest point using a cryostat, and fiber diameters were measured from hematoxylin and eosin stained sections. Fiber measurements were carried out on 250 fibers per animal, and mean fiber diameters were calculated for each animal. For plotting the distribution of fiber sizes, all data for a given genotype were pooled.
###end p 46
###begin p 47
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001628-Lee3">[15]</xref>
###xml 138 143 <span type="species:ncbi:10090">Mouse</span>
For analysis of myostatin protein, the myostatin latent complex was partially purified based on its ability to bind hydroxylapatite [15]. Mouse serum was diluted five-fold with 50 mM Tris pH 7.4 and bound to hydroxylapatite. After washing the column with 50 mM sodium phosphate pH 7.2, the myostatin latent complex was eluted with 200 mM sodium phosphate pH 7.2. The eluate was dialyzed, lyophilized, and subjected to Western analysis.
###end p 47
###begin p 48
I thank Charles Hawkins and Ann Lawler for carrying out the blastocyst injections and embryo transfers.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Regulation of muscle mass by myostatin.
###end article-title 50
###begin article-title 51
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Regulation of skeletal muscle mass in mice by a new TGF-ss superfamily member.
###end article-title 51
###begin article-title 52
###xml 18 24 <span type="species:ncbi:9913">bovine</span>
###xml 79 85 <span type="species:ncbi:9913">cattle</span>
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle.
###end article-title 52
###begin article-title 53
###xml 77 83 <span type="species:ncbi:9913">cattle</span>
Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle.
###end article-title 53
###begin article-title 54
###xml 19 25 <span type="species:ncbi:9913">cattle</span>
Double muscling in cattle due to mutations in the myostatin gene.
###end article-title 54
###begin article-title 55
###xml 120 126 <span type="species:ncbi:9913">cattle</span>
Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle.
###end article-title 55
###begin article-title 56
###xml 111 116 <span type="species:ncbi:9940">sheep</span>
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep.
###end article-title 56
###begin article-title 57
###xml 103 107 <span type="species:ncbi:9615">dogs</span>
A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs.
###end article-title 57
###begin article-title 58
###xml 65 70 <span type="species:ncbi:9606">child</span>
Myostatin mutation associated with gross muscle hypertrophy in a child.
###end article-title 58
###begin article-title 59
Functional improvement of dystrophic muscle by myostatin blockade.
###end article-title 59
###begin article-title 60
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.
###end article-title 60
###begin article-title 61
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.
###end article-title 61
###begin article-title 62
Myostatin propeptide-mediated amelioration of dystophic pathophysiology.
###end article-title 62
###begin article-title 63
Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
###end article-title 63
###begin article-title 64
Regulation of myostatin activity and muscle growth.
###end article-title 64
###begin article-title 65
GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding.
###end article-title 65
###begin article-title 66
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Induction of cachexia in mice by systemically administered myostatin.
###end article-title 66
###begin article-title 67
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum.
###end article-title 67
###begin article-title 68
Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains.
###end article-title 68
###begin article-title 69
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
###end article-title 69
###begin article-title 70
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Quadrupling muscle mass in mice by targeting TGF-ss signaling pathways.
###end article-title 70
###begin article-title 71
Developmental roles of the BMP1/TLD metalloproteinases.
###end article-title 71
###begin article-title 72
Mammalian BMP-1/tolloid-related metalloproteinases, including novel family member mammalian tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis.
###end article-title 72
###begin article-title 73
Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues.
###end article-title 73
###begin article-title 74
Characterization of a novel gene product (mammalian tolloid-like) with high sequence similarity to mammalian tolloid/bone morphogenetic protein-1.
###end article-title 74
###begin article-title 75
###xml 134 144 134 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 134 144 <span type="species:ncbi:7227">Drosophila</span>
Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid.
###end article-title 75
###begin article-title 76
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tll1</italic>
The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart.
###end article-title 76
###begin p 77
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Under a licensing agreement between MetaMorphix, Inc. (MMI) and the Johns Hopkins University, the author is entitled to a share of royalty received by the University on sales of the factor described in this paper. Both the author, who is the scientific founder of MMI, and the University own MMI stock, which is subject to certain restrictions under University policy. The author is a paid consultant to MMI and to Merck on research areas related to the study described in this paper. The terms of these arrangements are being managed by the University in accordance with its conflict of interest policies.
###end p 77
###begin p 78
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Institutes of Health (R01HD35887 and U54AR052646), a grant from the Muscular Dystrophy Association (MDA3765), and a gift from Merck Research Laboratories. None of the sponsors played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.
###end p 78

